Macrilen is a Oral Granule, For Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Macimorelin.
| Product ID | 0169-1401_5f3f501c-3f74-44ba-bc9c-7a9ee78576b3 | 
| NDC | 0169-1401 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Macrilen | 
| Generic Name | Macimorelin Acetate | 
| Dosage Form | Granule, For Solution | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2022-01-31 | 
| Marketing Category | NDA / | 
| Application Number | NDA205598 | 
| Labeler Name | Novo Nordisk | 
| Substance Name | MACIMORELIN | 
| Active Ingredient Strength | 60 mg/mg | 
| Pharm Classes | Growth Hormone Secretagogue Receptor Agonist [EPC], Growth Hormone Secretagogue Receptor Agonists [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2022-01-31 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0169-1401 | Macrilen | Macimorelin acetate | 
| 71090-002 | Macrilen | Macimorelin acetate | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() MACRILEN  98886441  not registered Live/Pending  | 
        AETERNA ZENTARIS GmbH  2024-12-05  | 
![]() MACRILEN  87978806  5624293 Live/Registered  | 
        AETERNA ZENTARIS GMBH  2017-09-08  | 
![]() MACRILEN  87601284  not registered Live/Pending  | 
        AETERNA ZENTARIS GMBH  2017-09-08  | 
![]() MACRILEN  87222769  5813944 Live/Registered  | 
        AEterna Zentaris GmbH  2016-11-01  | 
![]() MACRILEN  86213980  not registered Dead/Abandoned  | 
        AETERNA ZENTARIS GMBH  2014-03-07  | 
![]() MACRILEN  86213977  not registered Dead/Abandoned  | 
        AETERNA ZENTARIS GMBH  2014-03-07  | 
![]() MACRILEN  86005271  not registered Dead/Abandoned  | 
        AEterna Zentaris GmbH  2013-07-09  |